Analysis: Synopsys-Coverity Deal Final
Ed Sperling, Semiconductor Engineering
March 26th, 2014
Analysis: Acquisition closes after just five weeks, setting No. 1 EDA company on a different but potentially lucrative path.
Synopsys’ acquisition of Coverity, which makes tools for testing and analyzing software, was made official yesterday. Now what?
That may be the $334 million question, which is the price Synopsys paid for the 11-year-old software tools vendor. Even Synopsys’ top executives are rather candid in their uncertainty about where this deal will lead, and they made no qualms about that at the Synopsys User Group this week. Dealing with a slew of companies ranging from McAfee to SAP to Barclays is well outside the EDA and IP space. But they’re certainly not questioning the value of the deal. As more of the functionality in hardware is controlled by software, this acquisition appears to be less of a leap than it looks from an EDA-centric vantage point.
Related News
- Analysis: In $2.5B Deal, Qualcomm & CSR Mesh
- Apache Design's Totem Software Adopted by Fujitsu Semiconductor for Power Noise and Reliability Analysis
- MunEDA WiCkeD Tool Suite to Enhance Circuit Analysis, Performance and Yield Optimization Has Been Selected by Toshiba
- Analysis: Why ARM-AMD makes sense
- Analysis: TI-National deal a smart use of cash
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |